Skip to main content

Bard Prohibited From Sealing IVC Filter Evidence Documents

Bard Prohibited From Sealing IVC Filter Evidence Documents

Bard Prohibited From Sealing IVC Filter Evidence Documents

Introduction

On January 15, U.S. District Judge David Campbell of the District of Arizona, overseeing thousands of lawsuits involving C.R. Bard's IVC filter, denied the company's request to seal certain evidence documents.

The document in question was admitted into evidence in the last IVC filter trial but only partially disclosed. The judge ruled that the admission of the evidence suspended an earlier protective order even if not actually presented in the court. Bard faces more than 5,700 IVC filter lawsuits over complications such as filter migration, fracture or embolization related to blood clot filters, such as the Recovery, G2, Eclipse models, and many others.

Similar cases are consolidated as a part of multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) for coordinated pretrial proceedings, overlooked by Judge David G. Campbell, in the United States District Court District of Arizona.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!